Maurice Chelli

Maurice Chelli, Ph.D has a diverse range of work experience. From 2004 to 2008, they worked as a Senior Consultant at Ernst & Young. In 2009, they joined Bionest Partners as an Associate Manager, where they managed teams and led over 80 consultancy projects for life sciences companies. Maurice also played a key role in business development and communication with clients. In 2012, Maurice moved to the Pierre Fabre Group, initially serving as the Corporate Development, Licensing and Acquisitions Manager, then as the VP of Corporate Development & Licensing, and finally as the Global Head of Corporate Development & Licensing. During this time, they focused on setting up partnerships, conducting market studies, and overseeing various strategic initiatives. Maurice also served as a Member of the Board for ORPHELIA Pharma and France Biotech starting in 2017 and 2016 respectively.

Maurice Chelli, Ph.D completed their education in Molecular Biology, earning a PhD from Pierre and Marie Curie University during 1997 to 2003.